Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation.
Brittany Z DashevskyChenpeng ZhangLi YanCindy YuanLingyun XiongYongmei LiuHaiyan LiuFeng-Ming Spring KongYonglin PuPublished in: European journal of hybrid imaging (2017)
MTVwb is a prognostic marker for OS in patients with Stage 3B NSCLC, independent of age, gender, treatment, and tumor histology.